BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20143418)

  • 1. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.
    Espinet B; Salaverria I; Beà S; Ruiz-Xivillé N; Balagué O; Salido M; Costa D; Carreras J; Rodríguez-Vicente AE; Luís García J; Hernández-Rivas JM; Calasanz MJ; Siebert R; Ferrer A; Salar A; Carrió A; Polo N; García-Marco JA; Domingo A; González-Barca E; Romagosa V; Marugán I; López-Guillermo A; Millá F; Luís Mate J; Luño E; Sanzo C; Collado R; Oliver I; Monzó S; Palacín A; González T; Sant F; Salinas R; Ardanaz MT; Font L; Escoda L; Florensa L; Serrano S; Campo E; Solé F
    Genes Chromosomes Cancer; 2010 May; 49(5):439-51. PubMed ID: 20143418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival.
    Halldórsdóttir AM; Sander B; Göransson H; Isaksson A; Kimby E; Mansouri M; Rosenquist R; Ehrencrona H
    Genes Chromosomes Cancer; 2011 Feb; 50(2):113-21. PubMed ID: 21117067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex landscape of genetic alterations in mantle cell lymphoma.
    Royo C; Salaverria I; Hartmann EM; Rosenwald A; Campo E; Beà S
    Semin Cancer Biol; 2011 Nov; 21(5):322-34. PubMed ID: 21945515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic genotyping reveals a hierarchy of genomic alterations in mantle cell lymphoma associated to cell proliferation.
    Hutter G; Scheubner M; Ott G; Zimmermann Y; Hübler K; Roth S; Stilgenbauer S; Kalla J; Stöcklein H; Hiddemann W; Dreyling M
    Ann Hematol; 2009 Sep; 88(9):821-8. PubMed ID: 19137297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis.
    Katzenberger T; Kienle D; Stilgenbauer S; Höller S; Schilling C; Mäder U; Puppe B; Petzoldt C; Sander S; Bullinger L; Stöcklein H; Kalla J; Hartmann E; Adam P; Ott MM; Müller-Hermelink HK; Rosenwald A; Ott G
    Br J Haematol; 2008 Aug; 142(4):538-50. PubMed ID: 18564361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.
    Salaverria I; Espinet B; Carrió A; Costa D; Astier L; Slotta-Huspenina J; Quintanilla-Martinez L; Fend F; Solé F; Colomer D; Serrano S; Miró R; Beà S; Campo E
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1086-97. PubMed ID: 18709664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH.
    Parry-Jones N; Matutes E; Morilla R; Brito-Babapulle V; Wotherspoon A; Swansbury GJ; Catovsky D
    Br J Haematol; 2007 Apr; 137(2):117-24. PubMed ID: 17391491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations.
    Sander S; Bullinger L; Leupolt E; Benner A; Kienle D; Katzenberger T; Kalla J; Ott G; Müller-Hermelink HK; Barth TF; Möller P; Lichter P; Döhner H; Stilgenbauer S
    Haematologica; 2008 May; 93(5):680-7. PubMed ID: 18367489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytogenetics of mantle cell lymphoma].
    Obukhova TN; Lorie IuIu; Vodinskaia LA; Alimova GA; Nikitin EA; Samoĭlova RS; Kaplanskaia IB; Domracheva EV
    Ter Arkh; 2004; 76(7):70-7. PubMed ID: 15379132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome.
    Michaux L; Wlodarska I; Theate I; Stul M; Scheiff JM; Deneys V; Ferrant A; Hagemeijer A
    Ann Hematol; 2004 Sep; 83(9):578-83. PubMed ID: 15138714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemic involvement is a common feature in mantle cell lymphoma.
    Ferrer A; Salaverria I; Bosch F; Villamor N; Rozman M; Beà S; Giné E; López-Guillermo A; Campo E; Montserrat E
    Cancer; 2007 Jun; 109(12):2473-80. PubMed ID: 17477385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.
    Salaverria I; Zettl A; Beà S; Moreno V; Valls J; Hartmann E; Ott G; Wright G; Lopez-Guillermo A; Chan WC; Weisenburger DD; Gascoyne RD; Grogan TM; Delabie J; Jaffe ES; Montserrat E; Muller-Hermelink HK; Staudt LM; Rosenwald A; Campo E
    J Clin Oncol; 2007 Apr; 25(10):1216-22. PubMed ID: 17296973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of chromosomal markers in the diagnosis of mantle cell lymphoma (MCL).
    Woroniecka R; Pieńkowska-Grela B; Grygalewicz B; Rygier J; Witkowska A; Rymkiewicz G; Jarosińska-Romejko J
    J Appl Genet; 2002; 43(4):545-53. PubMed ID: 12441639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas.
    Belaud-Rotureau MA; Parrens M; Dubus P; Garroste JC; de Mascarel A; Merlio JP
    Mod Pathol; 2002 May; 15(5):517-25. PubMed ID: 12011256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
    Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
    Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value.
    Jardin F; Picquenot JM; Parmentier F; Ruminy P; Cornic M; Penther D; Bertrand P; Lanic H; Cassuto O; Humbrecht C; Lemasle E; Wautier A; Bastard C; Tilly H
    Br J Haematol; 2009 Sep; 146(6):607-18. PubMed ID: 19594747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
    Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
    Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytogenetic study of mantle cell lymphoma].
    Wang DM; Fan L; Fang C; Zhu DX; Dong H; Yang H; Qiu HR; Hong M; Qiao C; Xu W; Li JY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):283-6. PubMed ID: 21644224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
    Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma.
    Stokke T; DeAngelis P; Smedshammer L; Galteland E; Steen HB; Smeland EB; Delabie J; Holte H
    Br J Cancer; 2001 Dec; 85(12):1900-13. PubMed ID: 11747333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.